112 related articles for article (PubMed ID: 37725334)
1. Cancer incidence in the US military: An updated analysis.
Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
[TBL] [Abstract][Full Text] [Related]
2. Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.
Bytnar JA; Enewold L; Shriver CD; Zhu K
Cancer Epidemiol; 2024 Apr; 89():102539. PubMed ID: 38340498
[TBL] [Abstract][Full Text] [Related]
3. Incidence rates of bladder and kidney cancers among US military servicemen: comparison with the rates in the general US population.
Bytnar JA; McGlynn KA; Kern SQ; Shriver CD; Zhu K
Eur J Cancer Prev; 2024 Mar; ():. PubMed ID: 38568164
[TBL] [Abstract][Full Text] [Related]
4. Incidence rates of oral cavity and oropharyngeal cancers among men: a comparison of active-duty military and general populations.
Bytnar JA; Shriver CD; Zhu K
Eur J Cancer Prev; 2022 Mar; 31(2):166-171. PubMed ID: 33990095
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in the U.S. military population: comparison with rates from the SEER program.
Zhu K; Devesa SS; Wu H; Zahm SH; Jatoi I; Anderson WF; Peoples GE; Maxwell LG; Granger E; Potter JF; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1740-5. PubMed ID: 19505907
[TBL] [Abstract][Full Text] [Related]
6. Incidence rates of digestive cancers among U.S. military servicemen: Comparison with the rates in the general U.S. population.
Bytnar JA; Shriver CD; Zhu K
PLoS One; 2021; 16(9):e0257087. PubMed ID: 34478468
[TBL] [Abstract][Full Text] [Related]
7. Brain cancer incidence: a comparison of active-duty military and general populations.
Bytnar JA; Lin J; Eaglehouse YL; Enewold L; Shriver CD; Zhu K
Eur J Cancer Prev; 2021 Jul; 30(4):328-333. PubMed ID: 32898014
[TBL] [Abstract][Full Text] [Related]
8. Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry.
Flanary JT; Lin J; Shriver CD; Zhu K
Cancer Med; 2023 Nov; 12(22):20989-21000. PubMed ID: 37902129
[TBL] [Abstract][Full Text] [Related]
9. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
[TBL] [Abstract][Full Text] [Related]
10. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
[No Abstract] [Full Text] [Related]
11. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
[TBL] [Abstract][Full Text] [Related]
12. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
[TBL] [Abstract][Full Text] [Related]
13. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
[TBL] [Abstract][Full Text] [Related]
14. Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.
Enewold LR; Zhou J; Devesa SS; Berrington de Gonzalez A; Anderson WF; Zahm SH; Stojadinovic A; Peoples GE; Marrogi AJ; Potter JF; McGlynn KA; Zhu K
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2369-76. PubMed ID: 21914838
[TBL] [Abstract][Full Text] [Related]
15. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
Lin J; Hu H; Shriver CD; Zhu K
Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
Lin J; McGlynn KA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
[TBL] [Abstract][Full Text] [Related]
17. Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military Population.
Owens S; Blando T; Tesema YB; Butts E; Newton J; Bristow R; Randall LM
Mil Med; 2020 Sep; 185(9-10):e1590-e1595. PubMed ID: 32495838
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract][Full Text] [Related]
19. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
20. Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003.
Enewold L; Zhou J; Devesa SS; Erickson RL; Zhu K; McGlynn KA
Mil Med; 2011 Oct; 176(10):1184-7. PubMed ID: 22128656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
